In the months after the 2024 election and before President Donald Trump’s second inauguration, healthcare executives paid ...
HHS Secretary Robert F. Kennedy Jr. said any staffers in the department who are "working for the pharmaceutical industry" ...
AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...
Much to the Democrats’ chagrin, Robert F. Kennedy Jr. is now the United States’ new Health and Human Services secretary.
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics ...
With Trump in office and Republicans controlling Congress, it’s time for the president to continue work he started and ...
10h
GlobalData on MSNZealand Pharma steadfastly upholds amylin-based obesity drug strategyZealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
Harmony Biosciences is facing more of a nightmare than sweet dreams on the road to securing a new use for its excessive ...
Patients in the United States pay the highest prescription drug prices in the world — on average four times what people in other developed countries pay for the exact same brand-name medications. What ...
In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...
Independent journalist Brittney Hopper says Health and Human Services Secretary RFK Jr wants to “expose corruption” in the FDA and big pharma. “Regardless of what you think about this man personally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results